HealthEquity, Inc. $HQY Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard trimmed its stake in HealthEquity by 0.9% in Q4, selling 77,721 shares and retaining 8,668,534 shares—about 10.15% of the company worth roughly $794.1 million.
• HealthEquity reported an earnings beat for the quarter with EPS of $0.95 versus $0.90 expected and revenue of $334.6 million, up 7.3% year‑over‑year; analysts forecast full‑year EPS of 3.84.
• Analyst sentiment is mixed: MarketBeat shows a consensus rating of "Moderate Buy" and a $111.79 price target, although several firms have recently lowered targets and Goldman Sachs downgraded the stock to a sell with a $89 target.

Vanguard Group Inc. lowered its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,668,534 shares of the company's stock after selling 77,721 shares during the quarter. Vanguard Group Inc. owned approximately 10.15% of HealthEquity worth $794,124,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Concurrent Investment Advisors LLC boosted its position in HealthEquity by 288.1% during the fourth quarter. Concurrent Investment Advisors LLC now owns 8,996 shares of the company's stock worth $824,000 after acquiring an additional 6,678 shares during the last quarter. NBC Securities Inc. acquired a new stake in HealthEquity during the fourth quarter worth approximately $83,000. Peregrine Capital Management LLC boosted its position in HealthEquity by 5.9% during the fourth quarter. Peregrine Capital Management LLC now owns 108,753 shares of the company's stock worth $9,963,000 after acquiring an additional 6,062 shares during the last quarter. B. Metzler seel. Sohn & Co. AG boosted its position in HealthEquity by 23.5% during the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 104,078 shares of the company's stock worth $9,535,000 after acquiring an additional 19,772 shares during the last quarter. Finally, Milestone Asset Management LLC boosted its position in HealthEquity by 7.8% during the fourth quarter. Milestone Asset Management LLC now owns 11,778 shares of the company's stock worth $1,079,000 after acquiring an additional 853 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Up 0.5%

Shares of HQY opened at $82.40 on Friday. The firm has a market cap of $6.96 billion, a PE ratio of 33.50, a price-to-earnings-growth ratio of 1.50 and a beta of 0.19. The company's fifty day moving average is $80.91 and its two-hundred day moving average is $88.00. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The company had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. The company's revenue for the quarter was up 7.3% on a year-over-year basis. Analysts forecast that HealthEquity, Inc. will post 3.84 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Weiss Ratings restated a "hold (c+)" rating on shares of HealthEquity in a research report on Thursday, January 22nd. The Goldman Sachs Group lowered shares of HealthEquity from a "neutral" rating to a "sell" rating and set a $89.00 price target on the stock. in a report on Friday, January 9th. BTIG Research decreased their price target on shares of HealthEquity from $130.00 to $110.00 and set a "buy" rating on the stock in a report on Tuesday, February 17th. Barrington Research decreased their price target on shares of HealthEquity from $125.00 to $110.00 and set an "outperform" rating on the stock in a report on Wednesday, March 18th. Finally, Royal Bank Of Canada decreased their price target on shares of HealthEquity from $110.00 to $100.00 and set an "outperform" rating on the stock in a report on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of "Moderate Buy" and a consensus price target of $111.79.

HealthEquity Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.